GLP-1 Receptor Agonists: The Next Multifunctional Class of Drugs
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are well established for the management of type 2 diabetes mellitus and obesity. However, growing evidence suggests that their therapeutic effects extend beyond glycemic control and weight reduction. This review summarizes the emerging pleiotropic effects of GLP-1 R...